ArticleCancer2016

Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.

A Ari Hakimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.